CircO2 Side Effects: Low Pressure and Medicine Checks
Affiliate disclosure: purchase links may earn us a commission at no extra cost to you. This is an independent document-based assessment.
Topic: Side Effects · See the evidence and qualifications below.

CircO2 side effects need to be considered alongside your medicines and baseline blood pressure. This page examines likely ingredient-related concerns, the limits of seller safety assurances and situations requiring professional review. The CircO2 review provides the broader evidence and buying assessment.
| Concern | Relevant feature | Evidence level | Action |
|---|---|---|---|
| Low blood pressure | Vascular-support positioning and seller caution. | Precaution; not measured product incidence. | Ask clinician before use. |
| Medicine combination | Hawthorn and sodium nitrite. | Ingredient-based concern. | Have pharmacist review full list. |
| Digestive intolerance | Hawthorn and sugar alcohols. | Ingredient information. | Stop and seek advice if troublesome. |
| Pregnancy or breastfeeding | Multi-ingredient formula. | Adequate product safety not established. | Hold pending maternity clinician advice. |
Possible side effects and what they would mean
CircO2’s adverse-effect frequency cannot be calculated from the available customer display. Seller reassurance is not a systematic harms study. Ingredient information suggests watching for digestive symptoms, dizziness or intolerance, without establishing product-specific rates. Assess a new symptom on its merits rather than dismissing it as a sign that circulation is improving.
- Hawthorn can cause dizziness, nausea, vomiting, diarrhea or muscle pain according to NCCIH. NCCIH [4]
- Mannitol and xylitol are relevant to digestive tolerance; the panel does not state their quantities.
- A rash or suspected allergic reaction needs appropriate assessment, especially if there is swelling or breathing difficulty.
- Stop use and seek advice for concerning symptoms; severe reactions need urgent care.
A seller statement that serious events have not been reported cannot establish zero risk. Reporting completeness, medical history and the number of exposed users are not controlled in a promotional page.
Caffeine, liver concerns and the limits of reassurance
The inspected formula is not a caffeine-based stimulant blend. Its circulation positioning still has physiological relevance, so caffeine absence does not guarantee safety. LiverTox has not implicated conventional hawthorn use in clinically apparent liver injury. That ingredient-specific reassurance is narrower than a safety conclusion for every user of this multi-ingredient product.
| Question | Evidence boundary |
|---|---|
| Is there caffeine on the panel? | Caffeine is not listed among the inspected ingredients. |
| Does hawthorn necessarily injure the liver? | LiverTox describes it as an unlikely cause of clinically apparent liver injury. NIH LiverTox [5] |
| Is the whole blend therefore proven safe? | No. Component exposure, contaminants, other medicines and individual health can alter risk. |
An unrelated regulatory alert about a similarly named botanical or a different route of sodium nitrite administration should not be presented as a documented CircO2 incident. The finished product needs its own evidence.
Medicine interactions: ask about the actual combination
Low pressure and multiple vascular agents make a pharmacist review especially useful. The seller already advises people with low blood pressure to consult a physician. Because CircO2 includes hawthorn and sodium nitrite with undisclosed individual amounts, do not assume a few hours between products removes all interaction concerns.
Bring the package rather than relying on the phrase “nitric oxide booster.”
| Medicine or context | Question to resolve | Reason for review |
|---|---|---|
| Antihypertensives | Could the combination worsen dizziness or low pressure? | Your baseline readings and treatment matter. |
| Prescribed nitrates or other vasodilators | Is this ingredient combination appropriate? | Potential additive vascular effects require individual assessment. |
| Erectile-dysfunction medicines | Does my cardiovascular status or treatment make the combination unsuitable? | Do not treat a supplement as automatically exempt from medicine checks. |
| Digoxin or heart-failure treatment | Is hawthorn appropriate with my regimen? | Herbal heart products need clinician oversight. NCCIH [4] |
These are precautionary review priorities, not proven product-specific contraindication rates or instructions to stop prescribed medicine. A clinician may recommend avoiding use, obtaining more formulation information or choosing a different approach.
Who should hold use pending professional review?
Some situations warrant delaying CircO2 until suitability is assessed. These include low pressure, cardiovascular treatment, pregnancy, breastfeeding, childhood and significant medical conditions. Hidden component doses weaken assumptions about exposure. Review the intended goal alongside safety, because a supplement may not be an appropriate response to the symptom prompting interest.
- Pregnant or breastfeeding: reliable product-specific safety evidence was not established.
- Children: this adult-oriented offer does not establish pediatric suitability.
- Upcoming surgery or a new diagnosis: tell the treating team about all supplements.
- Chest pain, fainting, severe breathlessness or sudden neurological change: seek urgent medical care.
FDA advises discussing supplements with a health professional because interactions and adverse effects can occur. FDA [6] Return to the main review for the balanced summary.
Frequently asked questions
Is dizziness a sign CircO2 is helping?
Does no caffeine mean no side effects?
Can I separate CircO2 and medicine by a few hours?
Should I worry about hawthorn and my liver?
Is CircO2 established as safe in pregnancy?
Complete CircO2 assessment series
Biraj Health Care is Biraj K.’s editorial identity. His M.Ed. in Health Education is from Tribhuvan University; it is not a medical licence. Method: a document-based assessment of the published panel, dated seller terms and cited human research. Ingredient studies and finished-formula evidence are distinguished; no hands-on testing or medical review is claimed.
Methodology · Sources Policy · Dietary Supplements Guide · Ingredient ResearchEducational information, not personal medical advice. Do not change prescribed treatment on the basis of this assessment.
Affiliate disclaimer: we may receive a commission from qualifying purchases through the marked links. Disclosure policy.
References
- NCCIH: Hawthorn, usefulness and safety
- NIH LiverTox: Hawthorn
- FDA: Dietary supplements and premarket approval
Product facts and transaction terms were checked against the seller’s dated product panel and offer on November 3, 2026. These establish advertised terms, not independent clinical outcomes.